Cargando…

Evaluation of symptoms in respiratory syncytial virus infection in adults: psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire™ symptom scores

BACKGROUND: The Respiratory Infection Intensity and Impact Questionnaire (RiiQ™) is a patient-reported outcome measure designed to assess symptoms and impacts of respiratory syncytial virus (RSV) infection. This study evaluated the construct validity, reliability, and responsiveness of the RiiQ™ Res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osborne, Richard H., Nelson, Lauren M., Fehnel, Sheri, Williams, Nicole, Bender, Randall H., Ziemiecki, Ryan, Gymnopoulou, Efi, De Paepe, Els, Vandendijck, Yannick, Norcross, Lindsey, Heijnen, Esther, Ispas, Gabriela, Comeaux, Christy, Callendret, Benoit, Chan, Eric K. H., Scott, Jane A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235291/ https://www.ncbi.nlm.nih.gov/pubmed/37261682 http://dx.doi.org/10.1186/s41687-023-00593-9

Ejemplares similares

Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study
por: Sadoff, Jerald, et al.
Publicado: (2021)

Phase 2b Study of an Ad26.RSV.preF Vaccine for Prevention of RSV-mediated Respiratory Tract Disease in Older Adults
por: Falsey, Ann, et al.
Publicado: (2021)

Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post‐discharge assessed by Respiratory Intensity and Impact Questionnaire
por: Falsey, Ann R., et al.
Publicado: (2021)

902. A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of a Single Immunization of Ad26.RSV.preF against RSV Infection in a Viral Challenge Model in Healthy Adults
por: DeVincenzo, John, et al.
Publicado: (2019)

Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries
por: Nguyen-Van-Tam, Jonathan S., et al.
Publicado: (2022)

Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study
por: Hartnett, Jessica, et al.
Publicado: (2022)

LB14. Efficacy and Immunogenicity of an Ad26.RSV.preF-based Vaccine in the Prevention of RT-PCR-confirmed RSV-mediated Lower Respiratory Tract Disease in Adults Aged ≥65 Years: A Randomized, Placebo-controlled, Phase 2b Study
por: Falsey, Ann R, et al.
Publicado: (2021)

Potential Neurocognitive Symptoms Due to Respiratory Syncytial Virus Infection
por: Andrade, Catalina A., et al.
Publicado: (2021)

Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months
por: Stuart, Arabella S V, et al.
Publicado: (2022)

Psychometric evaluation of a caregiver diary for the assessment of symptoms of respiratory syncytial virus
por: Williams, Valerie, et al.
Publicado: (2018)

Diagnosis of Respiratory Syncytial Virus Infection
por: Popow-Kraupp, Therese, et al.
Publicado: (2011)

Incidence of respiratory viral infection in infants with respiratory symptoms evaluated for late-onset sepsis
por: Cerone, J B, et al.
Publicado: (2017)

Factors Contributing to Symptom Duration and Viral Reduction in Outpatient Children With Respiratory Syncytial Virus Infection
por: Utsunomiya, Takeshi, et al.
Publicado: (2020)

Development and psychometric evaluation of the Diabetic Gastroparesis Symptom Severity Diary
por: Fehnel, Sheri, et al.
Publicado: (2019)

Systematic literature review of the signs and symptoms of respiratory syncytial virus
por: Colosia, Ann, et al.
Publicado: (2023)

Risk factors for disease severity and increased medical resource utilization in respiratory syncytial virus (+) hospitalized children: A descriptive study conducted in four Belgian hospitals
por: Proesmans, Marijke, et al.
Publicado: (2022)

Evaluation of Clinical Case Definitions for Respiratory Syncytial Virus Lower Respiratory Tract Infection in Young Children
por: Englund, Janet A, et al.
Publicado: (2023)

The prevention of respiratory syncytial virus infection
por: Bollani, L, et al.
Publicado: (2014)

Respiratory Syncytial Virus Infection and Bronchiolitis
por: Piedimonte, Giovanni, et al.
Publicado: (2014)

Severe Respiratory Syncytial Virus Infection
por: Kashiwagi, Yasuyo, et al.
Publicado: (2019)

In vitro and in vivo evaluation of cerium oxide nanoparticles in respiratory syncytial virus infection
por: Patel, Akhil, et al.
Publicado: (2022)

Respiratory Syncytial Virus and Other Pediatric Respiratory Virus Infections
por: L., G.
Publicado: (1998)

Respiratory Syncytial Virus: An Underrecognized Healthcare-Associated Infection
por: Gettler, Erin, et al.
Publicado: (2021)

Qualitative interviews in patients with lipodystrophy to assess the patient experience: evaluation of hunger and other symptoms
por: Martin, Susan A., et al.
Publicado: (2022)

An evaluation of the emerging interventions against Respiratory Syncytial Virus (RSV)-associated acute lower respiratory infections in children
por: Nair, Harish, et al.
Publicado: (2011)

Influenza and respiratory syncytial virus infections in British Hajj pilgrims
por: Rashid, H, et al.
Publicado: (2008)

Receptors for Respiratory Syncytial Virus Infection and Host Factors Regulating the Life Cycle of Respiratory Syncytial Virus
por: Feng, Ziheng, et al.
Publicado: (2022)

Respiratory syncytial virus infection: an innate perspective
por: Johansson, Cecilia
Publicado: (2016)

Animal models of respiratory syncytial virus infection
por: Taylor, Geraldine
Publicado: (2017)

Respiratory Syncytial Virus Infection in Elderly Adults
por: Falsey, Ann R., et al.
Publicado: (2012)

Host Responses to Respiratory Syncytial Virus Infection
por: Agac, Ayse, et al.
Publicado: (2023)

The Changing Landscape of Respiratory Syncytial Virus Infections
por: Bem, Reinout A., et al.
Publicado: (2023)

Evaluation of the ImmuView RSV Test for Rapid Detection of Respiratory Syncytial Virus in Adult Patients with Influenza-Like Symptoms
por: Larsson, E., et al.
Publicado: (2021)

Respiratory-syncytial virus immunoprophylaxis on asthma symptoms development in prematurity with bronchopulmonary dysplasia
por: Fang, Li-Ching, et al.
Publicado: (2023)

Evaluation of Alere i RSV for Rapid Detection of Respiratory Syncytial Virus in Children Hospitalized with Acute Respiratory Tract Infection
por: Peters, Rebecca Marie, et al.
Publicado: (2017)

Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine
por: Jordan, Elke, et al.
Publicado: (2023)

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults
por: Salaun, Bruno, et al.
Publicado: (2023)

Molecular epidemiology of human respiratory syncytial virus (HRSV) in Iranian military trainees with acute respiratory symptoms in 2017
por: Niya, Mohammad Hadi Karbalaie, et al.
Publicado: (2020)

Systemic Signature of the Lung Response to Respiratory Syncytial Virus Infection
por: Pennings, Jeroen L. A., et al.
Publicado: (2011)

Role of chemokine receptor 5 during respiratory syncytial virus infection
por: Haeberle, HA, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_7k6dk8ln2kfb8plpsjiop13nbu